Mankind Pharma Limited has informed the Exchange about Link of Recording
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has shared the audio recording link of its Q4 and FY25 earnings conference call held on May 21, 2025 with senior management. The recording is available on the company's website. This is a routine compliance disclosure under SEBI listing regulations, following the earlier intimation of the call dated May 12, 2025. No new financial details or strategic updates are included in this filing itself.
No direct impact on the stock price; this is a procedural disclosure. Investors interested in management's commentary on FY25 results can listen to the full earnings call recording for qualitative guidance.